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The discovery of light-inducible protein–protein interactions has
allowed for the spatial and temporal control of a variety of bi-
ological processes. To be effective, a photodimerizer should have
several characteristics: it should show a large change in binding
affinity upon light stimulation, it should not cross-react with other
molecules in the cell, and it should be easily used in a variety of
organisms to recruit proteins of interest to each other. To create
a switch that meets these criteria we have embedded the bacterial
SsrA peptide in the C-terminal helix of a naturally occurring photo-
switch, the light-oxygen-voltage 2 (LOV2) domain from Avena sativa.
In the dark the SsrA peptide is sterically blocked from binding
its natural binding partner, SspB. When activated with blue light,
the C-terminal helix of the LOV2 domain undocks from the protein,
allowing the SsrA peptide to bind SspB. Without optimization, the
switch exhibited a twofold change in binding affinity for SspB
with light stimulation. Here, we describe the use of computational
protein design, phage display, and high-throughput binding assays
to create an improved light inducible dimer (iLID) that changes its
affinity for SspB by over 50-fold with light stimulation. A crystal
structure of iLID shows a critical interaction between the surface
of the LOV2 domain and a phenylalanine engineered to more tightly
pin the SsrA peptide against the LOV2 domain in the dark. We
demonstrate the functional utility of the switch through light-
mediated subcellular localization in mammalian cell culture and
reversible control of small GTPase signaling.
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Inducible protein dimers are complexes that form when a spe-cific stimulus is provided; for example, the protein FRB binds
to the protein FKBP12 in the presence of rapamycin (1). In-
ducible dimers are powerful research tools because with genetic
engineering they can be used to localize and activate proteins in
living systems (2–5). For example, by fusing one half of an in-
ducible dimer to a DNA binding domain and the other half to
a transcription activation domain, transcription of target genes
can be initiated by providing the stimulus that induces dimer-
ization. Chemically induced dimers have been used to control
a wide variety of biological processes but are limited by irrevers-
ibility and lack of spatial control within a cell. For this reason, there
is strong interest in light-inducible dimers (LIDs) that can be ac-
tivated in specific regions of a cell or an organism using light in
a reversible manner.
Several LIDs are currently available and have been used to
control signaling pathways in living cells. In almost all cases, the
dimers are derived from naturally occurring photoactivable sys-
tems. The most widely used pair thus far is cryptochrome 2 (Cry2)
and CIB1 from Arabidopsis thaliana. The Cry2/CIB1 pair shows
blue light induced dimerization in both yeast and mammalian cell
culture. Association occurs on a subsecond time scale and re-
version within 10 min (4). The mechanism of light-activation is not
fully understood and it has recently been shown that Cry2 oligo-
merizes into large clusters under blue light in addition to associ-
ating with CIB1. This could be a drawback for applications that
require precise stoichiometry, but the oligomerization itself has
been used for control of protein activation (6). Another di-
merization pair is phytochrome B (PhyB) and PIF, also from
A. thaliana. PhyB and PIF interact after irradiation with red light
and dissociate with exposure to far-red light (3). This system requires
a chromophore, phycocyanobilin that is not naturally present in
many organisms, including mammals (7, 8). The tunable light-
controlled interacting protein tags (TULIPs) make use of the blue
light-sensing light-oxygen-voltage (LOV) domain and an engi-
neered PDZ domain (9). Subcellular localization has been shown
with TULIPs in both yeast and mammalian cells. However, the
presence of a PDZ binding peptide and PDZ domain in the sys-
tem could lead to cross-talk with endogenous signaling pathways.
The FKF1/GIGANTEA (GI) heterodimer pair from A. thaliana
also relies on a LOV domain for light-activated binding. This pair
dimerizes in response to blue light in mammalian cells, associating
within a few minutes of activation and dissociating on the order of
a few hours (2). However, GI is a very large protein and the
switching power of the pair is sensitive to expression levels.
An ideal LID would be small and modular, associate quickly in
the presence of signal and quickly dissociate in its absence, and
be fully orthogonal to the organisms in which they are to be used.
To fulfill these criteria, we chose to use the LOV2 domain of
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phototropin 1 from Avena sativa (As) as the photoactive element
of our LID. In its native setting, the AsLOV2 domain senses blue
light and activates a C-terminal kinase domain. AsLOV2 can be
genetically encoded and its chromophore, flavin mononucleotide,
is abundant in most organisms. It is monomeric in dark state and
remains so under activating blue light. The structure of AsLOV2
has been determined, making it amenable to structure-guided
engineering. AsLOV2 is made up of a core per-arnt-sim (PAS)
fold with flanking α-helicies on the N- and C-termini (10). Upon
blue light irradiation, a conserved cysteine residue in the core of
AsLOV2 becomes covalently bound to the flavin cofactor, struc-
tural rearrangement is passed along through the PAS fold, and
ultimately the flanking helices unfold from the PAS core (11, 12).
The covalent bond breaks with a half-life of 30–50 s, and the helices
refold to their dark-state conformation (13, 14). To reengineer the
AsLOV2 domain to be part of a light-inducible complex, we in-
corporated a naturally occurring binding element within the protein:
seven residues of the Escherichia coli SsrA peptide that bind SspB,
a 13-kD adaptor protein also from E. coli. Both SsrA and SspB
have been structurally characterized and the SsrA peptide shares
sequence identity with the Jα helix of AsLOV2 (15–17). We
previously showed that incorporation of SsrA into the Jα helix of
AsLOV2 led to steric occlusion of SspB binding in the dark and
uncaging with blue light irradiation, yielding a light-inducible
heterodimer pair (18). Our original light-inducible dimer (oLID),
although containing some of the characteristics desirable for
a versatile tool, did not show large changes in binding affinity with
light stimulation. Original fusions of AsLOV2 and SsrA yielded
a twofold change in affinity for SspB. This was improved to an
eightfold switch by incorporating mutations known to stabilize the
Jα helix in the dark, as well as including a C-terminal phenylala-
nine predicted by molecular modeling to further hold the Jα helix
against the PAS domain in the dark. However, even in its final
form, dimerization in the dark at moderate protein concentrations
prevented large light-induced phenotypic changes in vivo.
To create a generalizable, versatile, and more powerful LID,
we sought to improve oLID with a novel combination of compu-
tational library design and phage-display screening. Using the
Rosetta macromolecular software suite, we ranked point mutations
within AsLOV2 and created a library of mutations with the goal of
improving the dynamic range of oLID, specifically reducing dark-
state binding. We then used phage-display and ELISA-based
binding assays to screen for mutations that both weakened dark-
state binding and responded to light activation. Here, we describe
two improved light-inducible (iLID) pairs that we identified with
this approach: iLID nano, which switches from 130 nM under blue
light to 4.7 μM in the dark, and iLID micro, which switches from
800 nM under blue light to 47 μM in the dark. iLID nano and iLID
micro both colocalize under blue light within seconds, revert to dark
state within minutes, and can be activated subcellularly in mam-
malian cell culture. To demonstrate functional utility in cells, we
show light-dependent control of GTPase activity and the cytoskel-
eton through localization of the DH/PH domains of Intersectin
(ITSN) and Tiam1.
Results
Computational Library Screened by Phage Display and Protein ELISA.
In oLID there was appreciable binding in the dark, ∼800 nM.
Previous studies suggest that a major source of dark state
“leakiness” comes from transient undocking and unfolding of
AsLOV2’s Jα-helix, and mutations that increase the intrinsic
stability of the Jα helix have proven successful in reducing dark-
state activity of light-activated AsLOV2 switches (9, 19). We
sought to extend this approach and use molecular modeling
combined with high-throughput screening to find mutations
throughout the domain that stabilize the docked state of the Jα-
helix. The pmut_scan protocol in Rosetta (20) was used to model
and score all possible point mutations within 6 Å of the Jα helix
using the crystal structure of AsLOV2 in its dark state (PDB ID
code 2V0U). All mutations that were predicted to be stabilizing
or neutral (within 1 kcal/mole of the wild-type residue) were
considered potential mutations that might stabilize the dark state
and were used as the basis for creating a directed library. The
final point-mutant library consisted of 743 mutations at 49
positions (SI Appendix, Table S4), and used the oLID sequence
as the starting sequence (Fig. 1A).
The oLID library was fused with the phage pIII coat protein
and an N-terminal Tat (twin-arginine translocation) secretion
sequence for display on the surface of phage (21). The Tat se-
cretion pathway was used because it maintains proteins in the
folded state during secretion, which allows them to remain
bound to cofactors. In this case this was critical, as FMN binding
is needed for LOV domain activity (Fig. 1B and SI Appendix, Fig.
S10). We screened the library by rounds of positive and negative
selection, binding under blue light to immobilized MBP-SspB and
subsequent elution in the dark (Fig. 1C). After four rounds of lit
and dark screening, individual sequences were tested by soluble
protein ELISA (Fig. 1D). We ranked mutations by change in
dynamic range, defined as ELISA signal under blue light/ELISA
signal in darkness. Single point-mutant LOV variants had minimal
improvement to overall switching. The top mutations were pooled
and recombined with each other to yield a recombined library.
Screening of the recombined library was repeated as before (Fig.
1E). The top 60 sequences had dynamic ranges ranging from 2.4 to
35.4 (SI Appendix, Fig. S1). Four sequences with the highest dy-





Fig. 1. Schematic overview of selection and screening protocol for improved
LOV variants. (A) Using Rosetta’s pmut_scan, we generated a library of point
mutations at 49 positions within the AsLOV2 domain (blue residues). (B) Phage-
display construct illustration. (C) The phage library was added to plates coated
with MBP-SspB (gray-blue) in the presence of blue light and washed. Plates were
moved to the dark and eluted phages were collected. (D) Top single-mutation
sequences were recloned as flag tag fusions and individually expressed. Binding
of soluble protein to MBP-SspB coated plates was measured after exposure to
blue light and sequestration in the dark by ELISA. (E) Mutations with the highest
dynamic range were recombined to generate a new library of LOV variants,
which was screened using the procedure shown in C and D.








In Vitro Characterization. We measured the binding affinity of our
four top sequences for SspB in the dark and after irradiation with
blue light using a competitive fluorescence polarization binding
assay. All four had improved dynamic ranges compared with the
parent clone oLID (Fig. 2 A and B) and switched roughly over
the same affinity range, ∼100 nM to <5 μM (SI Appendix, Fig.
S3). Clones D5 and F2 had the highest dynamic range of the
clones tested: 43-fold and 36-fold changes, respectively. D5
switched from 77 nM under blue light to 3.4 μM in the dark
and F2 switched from 132 nM under blue light to 4.7 μM in the
dark. As dark-state activity can be the limiting factor in the
usefulness of light-inducible tools, we chose to move forward
with clone F2, naming it our improved light-inducible dimer,
iLID (Fig. 2 C and E).
The concentration threshold required for activity varies for
different signaling proteins within a cell. Having tools that switch
over different ranges of affinities may allow a wider range of
targets to be controlled. To create an alternate affinity range for
iLID as well as retain our improved switching, we made a point
mutant, R73Q to SspB, reducing the peptide/protein affinity to
900 nM (SI Appendix, Fig. S4). In the context of SspB R73Q,
iLID has an affinity of 800 nM for SspB R73Q under blue light
and a dark-state affinity of 47 μM, which is a 58-fold change in
binding affinity (Fig. 2D). Thus, two sets of tools are available for
light-inducible heterodimerization: iLID nano (makes use of
wild-type SspB) and iLID micro (makes use of SspB R73Q).
Comparisons of the affinity ranges of these tools to their prede-
cessors can be seen in Fig. 2F.
Structural Characterization of iLID. iLID contains 10 mutations
compared with oLID. Four of the mutations are clustered in the
hinge loop that connects the PAS domain to the Jα helix, four
are located in the Jα helix, and two are in the PAS domain. To
investigate how these mutations are improving the dynamic
range of the switch, we solved the crystal structure of iLID in its
dark state to a resolution of 2.05 Å (Fig. 3). In general, there are
very few structural perturbations when comparing iLID to
AsLOV2. Within the core PAS domain (residues 413–516), the
Cα RMSD between iLID and AsLOV2 is 0.42 Å, and the hinge
loop showed almost no movement in the protein backbone (0.23
Å Cα RMSD) (Fig. 3B). Several of the side-chains in the hinge
region are forming interactions that may be important for sta-
bilizing the dark state of the switch. R519 is packed against W491
from the PAS domain. The isoleucine replacing valine 520 is
buried against side-chains from the Jα helix and the PAS domain
and packs against a valine at position 493 that is a leucine in
AsLOV2. The last residue in the hinge, position 522, is an
aspartic acid in AsLOV2 and a glycine in iLID. This is the last
residue before the Jα helix and has a positive ϕ angle: ϕ = 49.0°,
ψ = −126°. Aspartic acids are observed in this region of the
ramachandran plot, but glycine is by far the most common amino
acid in this region of the plot. In a set of high-resolution crystal
structure, 47% of the residues with ϕ near 50° and ψ near −130°







Fig. 2. Characterization of iLID nano and iLID micro. Competitive fluores-
cence polarization binding assays measure affinities of heterodimerization
under blue light (○) and in the dark (●). (A) Incorporation of SsrA into final
turn of the AsLOV2 Jα helix. (B) Addition of helix-strengthening mutations
(G528A, N538E) and C-terminal phenylalanine. (C) Top sequence from phage
display and screening, iLID, has a 36-fold change in affinity for SspB because
of light. (D) A mutation to SspB (R73Q) yields a heterodimer pair that
switches over the micromolar range of affinities with a 58-fold change in
affinity. (E) Sequence alignment of starting, oLID, and iLID. Black, unmu-
tated; gray, similar amino acid mutation. Gray dots indicate iLID mutations
that converged in all top four sequences. (F) Comparison of lit (○) and dark
(●) affinities between the original heterodimer pairs and our two new pairs,
iLID nano and iLID micro.
Fig. 3. Structure of iLID yields insight to role of mutated residues. (A)
Overall topology iLID (green) remains unchanged from AsLOV2. Boxes sur-
round three areas of interest to be shown in B, C, and D. (B) Alignment with
AsLOV2 (PDB ID code 2V0U, purple) reveals no major backbone rearrange-
ment of the hinge region due to mutations. (C) Close up view of A’α helix
from iLID (green), AsLOV2 (purple), and PA-Rac1 (PDB ID code 2WKP, dark
green), show different orientation in caged LOV variants from uncaged. (D)
SsrA epitope (blue) contains an extra helical turn before wrapping back and
interacting with the PAS fold. Designed C-terminal phenylalanine (green)
packs nicely into a hydrophobic pocket of the LOV domain.
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suggests that there may be some strain that is relieved when the
aspartic acid is mutated to a glycine.
The largest conformational change in the iLID structure was
in the N-terminal residues and the A’α helix. The first two re-
solved residues, T406 and T407, point toward the Jα helix instead
of the Dα helix, as in AsLOV2, and the A’α helix is shifted by 3 Å
(Fig. 3C). A smaller ∼1 Å movement is seen in the last 12 residues
of the Jα helix toward the A’α helix, allowing for tighter packing
between the two. The slight unwinding of the A’α helix allows for
the terminal nitrogen of the helix to be capped by E546 of the
SsrA sequence. Additionally, the side-chain of E409 forms a hy-
drogen bond with the tyrosine from the SsrA sequence.
Finally, the structure of iLID revealed the location and con-
formation of the caged SsrA peptide. The designed C-terminal
phenylalanine, F549, fits into a hydrophobic pocket on the sur-
face of the PAS domain made up of I417, I428, F429, and Y508
(Fig. 3D). SsrA makes three hydrogen bonds with the rest of the
LOV domain, all within the A’α helix. The carboxyl group of
D545 interacts with the hydroxyl of T406, the carboxyl group
of E546 with the backbone amide of L407, and the hydroxyl of
Y548 with the carboxyl of E409. In comparison with AsLOV2,
F549 occupies the same area as the C-terminal L546. Because of
extra residues in iLID, the last turn of the Jα helix buckles out
and wraps back in to make this placement of F549 possible. iLID
atomic coordinates and structure factors have been deposited to
the Protein Data Bank (PDB ID code 4WF0).
Reversion and Paired Down iLID. Based on the structure of iLID,
we chose six mutations to revert to determine their role or ne-
cessity in the improved switching of iLID (SI Appendix, Figs. S5
and S6, and Table S2). Reversion of R519 and D522 led to
a lower dynamic range and weaker caging, which is apparent as
tighter affinities under blue light and in the dark. Removal of
F537 had a similar effect on dynamic range, but weakened blue-
light and dark-state affinities for SspB to the micromolar range.
The remaining three reversions, Y502Q, H521R, and C530M,
had little effect on the dynamic range. The double-reversion
mutant, Y502Q/H521R, binds about threefold tighter in both
states. In addition to keeping the improved dynamic range,
C530M has very little effect on the affinity range or reversion
kinetics of the switch and can be removed without consequence
(SI Appendix, Fig. S9).
Subcellular Recruitment. Because oLID was previously untested in
mammalian cell culture, we were interested in how well it would
function and if the improvements of iLID, measured in vitro,
would be apparent in cells. To test LID function in cells, we
designed constructs by fusing the LIDs to the yellow fluorescent
protein, Venus, and a well-characterized peptide sequence that
would anchor the protein to specific subcellular localizations
(CAAX, cell membrane; Mito, mitochondria). Furthermore,
SspB (Nano) and SspB R73Q (Micro) were fused to the red
fluorescent protein, TagRFP-T (22). IA32 mouse fibroblasts (23)
transiently expressing the LID protein pairs were imaged using
a confocal microscope and activated with a 488-nm laser. To
assay whole-cell activation, cells expressing TagRFP-T-SspB and
the Mito anchored LID pairs were imaged during a time course
of intermittent whole cell 488-nm light stimulation. Cells ex-
pressing each pair of switches showed rapid recruitment of
TagRFP-T to the mitochondria during stimulation followed by
dissociation into the cytoplasm with the removal of stimulus (Fig.
4A, Upper, and Movie S1). Recruitment for each pair was
quantified and compared between switches by measuring the
ratio of mitochondrial/cytoplasmic TagRFP-T fluorescence in-
tensity throughout time (Fig. 4B). To prevent bias, mitochondrial
and cytoplasmic regions of interest (ROIs) were automatically
identified for each frame using the Venus channel and the de-
fault Threshold function in FIJI software. The recruitment phase
was fit to a single-phase exponential and we determined that the
iLID/Nano and iLID/Micro pairs showed a 4.4- and 4.3-fold
change in comparison with a 2.4-fold change seen for oLID/
Nano in this assay; each with a half-life < 30 s. Furthermore,
we hypothesized that the ratio of mitochondrial/cytoplasmic
TagRFP-T fluorescence in the dark state would be representa-
tive of the dark-state binding affinities observed in vitro. As
expected, the iLID/Nano dark state ratio is higher than the ratio
for iLID/Micro. However, although the in vitro evidence would
suggest that oLID/Nano would have the tightest binding affinity
in the dark, their dark-state mitochondrial/cytoplasmic TagRFP-T
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Fig. 4. iLID provides improved local recruitment in cell culture. (A) IA32 fibroblasts expressing membrane (CAAX) and mitochondrial anchored Venus-iLID
and cytoplasmic TagRFP-T-Nano. Localized activation (denoted by blue markings) caused relocalization of TagRFP-T-Nano. (Scale bar, 50 μm.) (B) A ratio of
mitochondrial to cytoplasmic TagRFP-T signal intensity during a time course of whole-cell activation as shown in row 1 of A for each pair of mitochondria
anchored switches. (C) Patterned activation of Venus-iLID-CAAX shows tight spatial and temporal control of TagRFP-T-Nano localization within a cell. (Scale
bar, 50 μm.)








To test if the LID proteins could be used to recruit protein to
a subcellular localization based on a ROI, the CAAX fused LID
pairs were expressed and imaged in fibroblasts (Fig. 4A, Lower,
and Movie S2). The optical sections obtained using the confocal
were thick enough to capture light emitted from both apical and
basal membrane bound proteins. This process allowed us to
stimulate ROIs on these membranes and image the relocaliza-
tion of TagRFP-T to these regions of the cell. Again, we imaged
cells with intermittent stimulation at a ROI. During stimulation
the TagRFP-T signal increased within the ROI but diminished
outside the ROI. From this assay it is difficult to determine
differences in dark-state binding because we do not know what
portion of TagRFP-T-SspB is membrane bound versus cyto-
plasmic. However, by quantifying the TagRFP-T fluorescence
intensity in a relatively small ROI (260 μm2), the cytoplasmic
concentration of TagRFP-T-SspB should remain constant before
and after 488-nm light stimulation. Therefore, by calculating pre:
post stimulation ratio of TagRFP-T fluorescence intensity within
the ROI, we determined the relative fold-change of binding in
the light and dark. These values correlate with in vitro measured
dynamic ranges (SI Appendix, Fig. S7). These experiments led us
to realize that by anchoring the switching half of the dimer pair
we obtained a relatively tight spatial resolution of activation.
Combined with the minute time scales of association and dis-
sociation, we were able to exemplify these attributes of the switch
by sequentially writing the letters i, L, I, and D on the membrane
of a cell (Fig. 4C and Movie S3).
Light-Induced GTPase Signaling Through Guanine Nucleotide Exchange
Factor Localization. One area of interest for the use of LIDs is to
control and study cell signaling. The Rho family of small GTPases
(consisting of RhoA, Rac1, and Cdc42) are signaling proteins
involved in many aspects of cell physiology, including actin cy-
toskeleton remodeling. In general, GTPase signaling is consid-
ered active when the GTPase is bound to GTP and inactive after
the GTPase hydrolyzes GTP to GDP. Canonically, active Rac1
leads to branched actin formation and lamellipodial morphology,
active Cdc42 leads to bundled actin and filopodial morphology,
and active RhoA leads to bundled actin and actin stress fiber
formation. Other groups have found that small GTPases can be
controlled through the localization of guanine nucleotide exchange
factor (GEF) Dbl homology (DH)/pleckstrin-homology(PH)
domains to the membrane (3, 24). At the membrane the DH/PH
domains are colocalized with GTPases, where they can aid in
exchange of GDP for GTP, activating the GTPases. We hypoth-
esized that the LID switches could be used to locally activate
GTPase signaling, leading to a change in actin dynamics and
a visible change in cell morphology (SI Appendix, Fig. S8A).
Therefore, we fused the DH/PH domains of ITSN (Cdc42 GEF)
and Tiam1 (Rac GEF) to the N terminus of the TagRFP-T-SspB
constructs (SI Appendix, Fig. S8B). Fibroblasts were transiently
transfected with each construct in combination with Venus-iLID-
CAAX using a 1:1 ratio of DNA. Because each construct is under
the control of a CMV promoter, we expect that on average each
construct is expressed at equal levels. Two days later the cells were
imaged and stimulated in a similar manner to the spot stimulation
previously described. Here, stimulated areas were at the edge of
the cell. As expected, the cells expressing the Tiam1 fusions,
within minutes of stimulation, began to ruffle and formed
a lamellipodia at the site of recruitment (Fig. 5A and Movie S4).
Surprisingly, the cells expressing the ITSN fusions displayed
a similar phenotype in the area of stimulation (Fig. 5B and
Movie S5). Although we would expect a filopodial morphology
to form, our results may be explained in two ways: cross-talk
between GTPase pathways that leads to an increase in Rac
GTPase signaling or a direct catalytic effect on a Rac GTPase,
such as RhoG, from the ITSN DH/PH (25, 26). In addition to
forming lamellipodia, most cells displayed increased appearance
of vesicles in the stimulated area consistent with the role of
Cdc42 in endocytosis (Fig. 5B, arrowheads, and Movie S6).
Discussion
A novel aspect of our study was the use of high-throughput
screening and selection to improve the dynamic range of a pho-
toactivatable protein switch. A specific challenge of engineering
a switch is that the selection protocol should be sensitive to
protein activity in both the on and off state. In our case, it was
critical that the LOV domain be presented on the surface of the
phage in a functional form. In phage display it is common to use
signal sequences that direct a protein to the Sec-mediated
translocation pathway, which transports proteins through mem-
branes in an unfolded state. This approach was not appropriate
for our application because we needed the LOV domain to re-
main folded during translocation so that it would remain bound
to the flavin cofactor. Therefore, we made use of the Tat se-
cretion pathway, which maintains proteins in a folded and
cofactor-bound state during secretion. Once the LOV domain was
on the surface of phage, we were able to find functional switches
by selecting for binding under blue light, and then collecting phage
that unbound when the light was turned off. The phage pro-
tocol was useful as a first filter in the search for better switches,
but explicit screening in the light and dark with the ELISA-
based binding assay allowed us to identify the top performing
variants. The ELISA was particularly informative because the
binding properties of single variants could be characterized
side-by-side in the light and dark. This process allowed us to
detect small improvements in switching, which allowed us to
select variants to include in the recombination library.
In creating the directed library, we used molecular modeling
to find mutations predicted to be compatible with the dark state
of the switch. We used this approach because we were interested
in stabilizing the closed state of the switch. Ideally, modeling
would be used to find mutations that are compatible with the
dark and lit state. This was not possible because there is not
detailed structural information about what happens to the PAS
domain when it is photoactivated. It is informative to see where
the final mutations were located in iLID. The cluster of mutations
in the hinge loop indicates that it has an important role in the
docking and undocking of the Jα helix. In a multiple sequence
alignment of the LOV domain, there is variability in the hinge
loop, suggesting that LOV-domain homologs may have different
switching properties.
Previous studies have highlighted the role of the A’α helix in
stabilizing the docked state of the Jα helix in the dark and releasing
it in the light (12). In the iLID structure the A’α helix rearranges to
form several contacts with the Jα helix and the embedded SsrA
sequence. Interestingly, the alternate conformation of the A’α
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Fig. 5. Spatial control of GEF DH/PH domains by iLID produces localized
control of Rac and Cdc42 activity. IA32 cells expressing Venus-iLID-CAAX and
(A) Tiam DH/PH-TagRFP-T-Nano or (B) ITSN DH/PH-TagRFP-T-Nano. iLID was
activated in the regions highlighted in blue. White arrowheads mark vesi-
cles. Images are representative (n > 5). (Scale bars, 50 μm.)
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another photoactivatable switch based on the AsLOV2 domain
(Fig. 3C). A shared feature of the iLID and PA-Rac1 structures
is the capping of the A’α helix. In the AsLOV2 structure, the A’α
helix is capped by a water molecule; however, in iLID the car-
boxyl group of E546 in SsrA caps the helix and in PA-Rac1 it is
capped by the carbonyl group of N595 in Rac1. These capping
interactions in Pa-Rac1 and iLID may enhance cooperativity
between folding of the A’α helix and caging, and therefore lead
to effective switching.
Our goal in creating iLIDs was to create a genetic tool for
studying biochemical and cellular processes. We showed that
both iLID pairs can be used in mammalian cell culture to form
dimers and recruit fusion proteins to subcellular structures.
Furthermore, the differing affinity ranges of iLID nano and iLID
micro, measured in vitro, translate to different cell characteristics
and can be used accordingly. We postulate that this inherent
tuneability of the switch will lead to use in a broader spectrum of
applications. Here, we were able to control local GTPase activity
by driving GEF DH/PH domains to a localized spot on the
membrane, and we expect that the small, modular nature of iLID
nano/micro will open up control of a much wider variety of
cellular targets.
Materials and Methods
Design and Construction of Computationally Directed Library. Rosetta’s
pmut_scan protocol was used to predict stability of all possible AsLOV2
point mutations. Stabilizing and mildly destabilizing mutations were fil-
tered for proximity to the Jα helix and a library of single point mutations
was generated using a comprehensive mutagenesis protocol (27). The
recombined point-mutant library was generated using a gene-assembly
protocol with oligonucleotides encoding for the top mutations suggested
by ELISA ranking. See SI Appendix for details.
Phage Display Selection and Ranking by Soluble Protein ELISA. The AsLOV2
library was cloned as a fusion with phage pIII coat protein and the Tat se-
cretion sequence. Phage expressing the library was added to plates coated
with MBP-SspB and placed under blue light, left for 1 h, washed, and moved
to the dark. After 10 min in the dark, the eluted phage was collected,
propagated, and quantified (28). Four rounds of positive and negative
selection were performed before cloning into a modified pET-21b vector
with an N-terminal FLAG tag. Overnight cultures were lysed and added to
plates with immobilized MBP-SspB under blue light and in the dark. ELISA
signal to anti-FLAG antibody was detected via ECL reagent. See SI Ap-
pendix for details.
Growth and Purification of Recombinant Proteins. Purified proteins were
prepared as previously published (18). See SI Appendix for details.
Fluorescence Polarization Binding Assays. Binding assays were performed as
previously described (18). See SI Appendix for details. All measured affinities
can be found in SI Appendix, Tables S1–S3.
Crystallization and Structural Determination of iLID. Initial crystals of iLID were
grown using hanging drop vapor diffusion with 800 mM lithium chloride,
100 mM Tris·HCl pH 8.5, 32% (wt/vol) PEG 4000. Crystals were optimized
with microseeding and grew to full size within 3 d. X-ray diffraction data
were collected at Southeast Regional Collaborative Access Team (SER-CAT)
22-ID beamline at the Advanced Photon Source, Argonne National Labo-
ratory. The structure was determined using molecular replacement with
PDB ID 2V0U. See SI Appendix for details.
Mammalian Cell Culture and Transfection. IA32 mouse fibroblast cells were
cultured at 37 °C and 5% (vol/vol) CO2 in DMEM supplemented with 10% FBS
(HyClone), 100 U/mL penicillin, 100 μg/mL streptomycin, and 292 μg/mL
L-glutamine. Cells were transiently transfected using NanoJuice (EMD
Millipore) as recommended by the manufacturer.
Mammallian Cell Localization/GEF Microscopy and Image Analysis. Fibroblasts
were transfected with two vectors containing each component of the switch
in equal amounts. Two days later, cells were imaged and photo-activated
with an Olympus FluoView FV1000 scanning confocal inverted microscope
equipped with a 1.30 N.A. 40× oil-immersion objective. Images were ana-
lyzed using FIJI software (29). See SI Appendix for details.
Cloning and Vector Information. See SI Appendix, Methods for details and
SI Appendix, Table S6 for a list of constructs and corresponding Addgene
numbers.
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